Serina Therapeutics, Inc. (SER)

NYSEAMERICAN: SER · Real-Time Price · USD

1.840

+0.030 (1.66%)

At close: Jun 12, 2026, 4:00 PM EDT

1.800

-0.040 (-2.17%)

After-hours: Jun 12, 2026, 6:41 PM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Research and Development of Its POZ Platform	130.00K	56.00K	3.15M	591.50K	3.46M
Research and Development of Its POZ Platform Growth	132.14%	-98.22%	433.05%	-82.93%	-
Total	130.00K	56.00K	3.15M	591.50K	3.46M
Total Growth	132.14%	-98.22%	433.05%	-82.93%	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
United States	130.00K	56.00K	3.15M	591.50K	3.46M
United States Growth	132.14%	-98.22%	433.05%	-82.93%	-
Total	130.00K	56.00K	3.15M	591.50K	3.46M
Total Growth	132.14%	-98.22%	433.05%	-82.93%	-